Evidence map›Paper›PMID 35309689›Full record

ArticleTransportation research. Part A, Policy and practice2022

Estimation of crowding factors for public transport during the COVID-19 pandemic in Santiago, Chile.

Paul Basnak, Ricardo Giesen, Juan Carlos Muñoz

Open access · greenAbstract read
In one paragraph

Article in Transportation research. Part A, Policy and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Paul BasnakPontificia Universidad Católica de Chile, Chile.
Ricardo GiesenPontificia Universidad Católica de Chile, Chile.
Juan Carlos MuñozPontificia Universidad Católica de Chile, Chile.
Pontificia Universidad Católica de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A sharp decrease in public transport demand has been observed during the COVID-19 pandemic around the world. In this context, it is relevant to understand how mode preferences have changed since the surge of COVID-19. In order to better understand how the pandemic changed mode choice, particularly regarding the impact of crowding and face mask use in public transport, we conducted a stated preference on-line and on-street survey in Santiago, Chile. Our sample is balanced in gender but has a higher proportion of individuals with college degrees and those under 45 years of age than the population of Santiago. The data collected was then used to estimate two multinomial mode choice models, a latent class model and a mixed logit model with latent variables. The models yielded a value of travel time in crowded conditions (4 pax/m2) and low face mask use (50%) of 3.0-5.1 times higher than the case with low crowding (0.5 pax/m2) and 100% face mask use. Moreover, women tend to be more sensitive than men to the use of face masks in public transport. Besides, young and low-income people are relatively less sensitive to crowding. The crowding penalization obtained is higher than in pre-pandemic models calibrated for Santiago for similar passenger densities. Also, as we expected, it grows non-linearly with passenger density. Disinfection of vehicles, as well as the perception of health risk, cleanliness, safety and comfort, were also relevant in explaining mode choice. Further research shall discuss how the change of mode preferences together with new demand patterns influence the operational design of public transport services.

Identifiers

PMID35309689
PMCPMC8920350
OpenAlexW4220890016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.